Should Patients Be Required to Undergo Standard Chemotherapy Before Being Eligible for Novel Phase I Immunotherapy Clinical Trials?
a Treuman Katz Center for Pediatric Bioethics and Seattle Children's Research Institute.
Benjamin S
BS
Wilfond
b Johns Hopkins Bloomberg School of Public Health and Johns Hopkins Berman Institute of Bioethics.
Christian
C
Morales
b Johns Hopkins Bloomberg School of Public Health and Johns Hopkins Berman Institute of Bioethics.
Holly A
HA
Taylor
D017321:Clinical Trials, Phase I as Topic / Q000941:ethics*; D004358:Drug Therapy; D006801:Humans; D007167:Immunotherapy; D009369:Neoplasms / Q000628:therapy*